Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romain David

Showing results (91-100 of 150) with videos related to

Pageof 15
Sort By:
Molecular Phylogenetics and Evolution|April 6, 2019
From seascape ecology to population genomics and back. Spatial and ecological differentiation among cryptic species of the red algae Lithophyllum stictiforme/L. cabiochiae, main bioconstructors of coralligenous habitatsAurélien De Jode, Romain David, Anne Haguenauer, et al.
Annals of Nuclear Medicine|October 18, 2020
FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancerRomain-David Seban, Jean-Baptiste Assie, Etienne Giroux-Leprieur, et al.
Neuromodulation : Journal of the International Neuromodulation Society|November 24, 2024
Comparison of Spinal Cord Stimulation, Dorsal Root Ganglion Stimulation, and Association of Both in Patients With Refractory Chronic Back and/or Lower Limb Neuropathic Pain: A Prospective, Randomized, Double-Blind, Cross-Over Trial (BOOST-DRG Study)Philippe Rigoard, Amine Ounajim, Bénédicte Bouche, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 25, 2020
Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4Romain-David Seban, Antoine Moya-Plana, Lara Antonios, et al.
Journal of Medical Internet Research|April 16, 2025
The Added Value of Digital Body Chart Pain Surface Assessment as an Objective Biomarker: Multicohort StudyMaxime Billot, Amine Ounajim, Maarten Moens, et al.
Abdominal Radiology (New York)|April 14, 2019
The role of multimodal imaging in guiding resectability and cytoreduction in pancreatic neuroendocrine tumors: focus on PET and MRILaura Rozenblum, Fatima-Zohra Mokrane, Randy Yeh, et al.
Marine Pollution Bulletin|May 20, 2017
An integrated method to evaluate and monitor the conservation state of coralligenous habitats: The INDEX-COR approachStéphane Sartoretto, Thomas Schohn, Carlo Nike Bianchi, et al.
Oncoimmunology|May 10, 2019
Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapyRomain-David Seban, Charlotte Robert, Laurent Dercle, et al.
Cancers|August 14, 2020
Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line PembrolizumabRomain-David Seban, Jean-Baptiste Assié, Etienne Giroux-Leprieur, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2019
Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitorsRomain-David Seban, Laura Mezquita, Arnaud Berenbaum, et al.
Pageof 15

Showing results (91-100 of 150) with videos related to

Sort By:
Pageof 15
Molecular Phylogenetics and Evolution|April 6, 2019
From seascape ecology to population genomics and back. Spatial and ecological differentiation among cryptic species of the red algae Lithophyllum stictiforme/L. cabiochiae, main bioconstructors of coralligenous habitatsAurélien De Jode, Romain David, Anne Haguenauer, et al.
Annals of Nuclear Medicine|October 18, 2020
FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancerRomain-David Seban, Jean-Baptiste Assie, Etienne Giroux-Leprieur, et al.
Neuromodulation : Journal of the International Neuromodulation Society|November 24, 2024
Comparison of Spinal Cord Stimulation, Dorsal Root Ganglion Stimulation, and Association of Both in Patients With Refractory Chronic Back and/or Lower Limb Neuropathic Pain: A Prospective, Randomized, Double-Blind, Cross-Over Trial (BOOST-DRG Study)Philippe Rigoard, Amine Ounajim, Bénédicte Bouche, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 25, 2020
Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4Romain-David Seban, Antoine Moya-Plana, Lara Antonios, et al.
Journal of Medical Internet Research|April 16, 2025
The Added Value of Digital Body Chart Pain Surface Assessment as an Objective Biomarker: Multicohort StudyMaxime Billot, Amine Ounajim, Maarten Moens, et al.
Abdominal Radiology (New York)|April 14, 2019
The role of multimodal imaging in guiding resectability and cytoreduction in pancreatic neuroendocrine tumors: focus on PET and MRILaura Rozenblum, Fatima-Zohra Mokrane, Randy Yeh, et al.
Marine Pollution Bulletin|May 20, 2017
An integrated method to evaluate and monitor the conservation state of coralligenous habitats: The INDEX-COR approachStéphane Sartoretto, Thomas Schohn, Carlo Nike Bianchi, et al.
Oncoimmunology|May 10, 2019
Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapyRomain-David Seban, Charlotte Robert, Laurent Dercle, et al.
Cancers|August 14, 2020
Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line PembrolizumabRomain-David Seban, Jean-Baptiste Assié, Etienne Giroux-Leprieur, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2019
Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitorsRomain-David Seban, Laura Mezquita, Arnaud Berenbaum, et al.
Pageof 15